Pharma-Bio Serv (PBSV) Total Debt (2020 - 2021)

Pharma-Bio Serv's (PBSV) quarterly Total Debt came in at $1.9 million in Q2 2021, little changed YoY from $1.9 million in Q2 2020, and little changed on a QoQ basis from $1.9 million in Q1 2021.

Pharma-Bio Serv (PBSV) Total Debt (2020 - 2021) Analysis & Trends

Pharma-Bio Serv (PBSV) has 2 years of Total Debt data on file, last reported at $1.9 million in Q2 2021.

  • Quarterly Total Debt changed 0.0% year-over-year to $1.9 million in Q2 2021, while the trailing twelve-month figure through Apr 2021 was $1.9 million (changed 0.0% YoY) and the FY2020 annual result came in at $1.9 million, changed N/A from the prior year.
  • Total Debt steadied at $1.9 million in Q2 2021, from $1.9 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $1.9 million in Q2 2020 to a low of $1.9 million in Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn -
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn 2.19 Bn
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn 942.66 Mn
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn -
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn -
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn -
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn 1.47 Bn
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn -
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn -
10 Pharma-Bio Serv 12.37 Mn 3.89 Mn 902,041.00 -

Historic Data

Download Data
DateValue
Apr 30, 2021 1.93 Mn
Jan 31, 2021 1.93 Mn
Oct 31, 2020 1.93 Mn
Jul 31, 2020 1.93 Mn
Apr 30, 2020 1.93 Mn